ARCHIVES

AHRQ Draft Report Finds No Benefit For Biomarker Testing In Oncology

This article is from The Cancer Letter archive.

Vol. 36 No. 04 | February 5, 2010

Download PDF Visit The Full Archive

Related Articles

Breast cancer session was ASCO equivalent of a rock concert, discussant says.

May 27, 2005

Amgen Agrees To Buy Immunex For $16 Billion In Stock And Cash.

January 25, 2002

Zytiga Plus Prednisone Shows Improvement in PFS and OS Over Prednisone Alone

June 29, 2012

New Mammography Guidelines Cut Uses By Women Under 50 t 25%

July 29, 1977

Funding Opportunities: NCI Offers Funds To Develop, Validate Mouse Models

November 20, 1998

Novartis Submits Gleevec Data To FDA Seeking Approval For Use In GI Tumors.

October 26, 2001